Close

Biogen (BIIB) Tecfidera Patient Starts Increase 4% WoW

March 28, 2014 9:04 AM EDT Send to a Friend
Biogen (NASDAQ: BIIB) Tecfidera TRx were up 1% at 6070 vs. 6,020 last week, said Deutsche Bank, citing IMS. NRx ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login